Detection of low avidity CD8+ T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers

Journal of Immunological Methods

Volumn 338, Issue 1-2, 2008, Pages 31-39

  Melenhorst, J Joseph ^a   Scheinberg, Phillip ^a,b   Chattopadhyay, Pratip K ^b   Lissina, Anna ^c   Gostick, Emma ^c   Cole, David K ^c   Wooldridge, Linda ^c   van den Berg, Hugo A ^d   Bornstein, Ethan ^b   Hensel, Nancy F ^a   Douek, Daniel C ^b   Roederer, Mario ^b   Sewell, Andrew K ^c   Barrett, A John ^a   Price, David A ^b,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Peptide major histocompatibility complex class I tetramer; Polychromatic flow cytometry; T cell

Indexed keywords

CD8 ANTIGEN; FLUORESCENT DYE; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOMER; POLYMER; T LYMPHOCYTE RECEPTOR; TETRAMER;

ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL POPULATION; CROSS REACTION; EX VIVO STUDY; FLOW CYTOMETRY; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; STAINING; VALIDATION PROCESS; WILD TYPE;

AMINO ACID SEQUENCE; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL;

EID: 50949109252     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.07.008     Document Type: Article

References (37)

1. Altman J.D., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94
2. Boulter J.M., et al. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16 (2003) 707
3. Cho B.K., Rao V.P., Ge Q., Eisen H.N., and Chen J. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192 (2000) 549
4. Choi E.M., et al. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J. Immunol. 171 (2003) 5116
5. Cole D.K., et al. Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 178 (2007) 5727
6. Diamond D.J., York J., Sun J.Y., Wright C.L., and Forman S.J. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90 (1997) 1751
7. Douek D.C., et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168 (2002) 3099
8. Gagnon S.J., et al. T cell receptor recognition via cooperative conformational plasticity. J. Mol. Biol. 363 (2006) 228
9. Gakamsky D.M., et al. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89 (2005) 2121
10. Gao G.F., et al. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387 (1997) 630
11. Gao L., et al. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95 (2000) 2198
12. + T cells in lymphopenic hosts. Immunity 11 (1999) 183
13. Hutchinson S.L., et al. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 278 (2003) 24285
14. + T cell cross-reactivity in individuals infected with hepatitis C virus. J. Clin. Invest. 118 (2008) 1143
15. Klenerman P., Cerundolo V., and Dunbar P.R. Tracking T cells with tetramers: new tales from new tools. Nat. Rev. Immunol. 2 (2002) 263
16. Krupica Jr. T., Fry T.J., and Mackall C.L. Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 120 (2006) 121
17. Laugel B., et al. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J. Biol. Chem. 280 (2005) 1882
18. Laugel B., et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282 (2007) 23799
19. Lee P.P., et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5 (1999) 677
20. Lyons G.E., et al. T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells. Cancer Immunol. Immunother. 55 (2006) 1142
21. Molldrem J., et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 88 (1996) 2450
22. Molldrem J.J., et al. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J. Clin. Invest. 111 (2003) 639
23. Oka Y., et al. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51 (2000) 99
24. Perfetto S.P., et al. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J. Immunol. Methods 313 (2006) 199
25. Pittet M.J., et al. alpha3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells. J. Immunol. 171 (2003) 1844
26. Price D.A., et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21 (2004) 793
27. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202 (2005) 1349
28. Purbhoo M.A., et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J. Biol. Chem. 276 (2001) 32786
29. Purbhoo M.A., et al. The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Mol. Cancer Ther. 6 (2007) 2081
30. Rubio-Godoy V., et al. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc. Natl. Acad. Sci. U S A 98 (2001) 10302
31. + T-cell cross-reactivity and heterologous immunity. Immunol. Rev. 211 (2006) 164
32. van den Berg H.A., Wooldridge L., Laugel B., and Sewell A.K. Coreceptor CD8-driven modulation of T cell antigen receptor specificity. J. Theor. Biol. 249 (2007) 395
33. Whelan J.A., et al. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163 (1999) 4342
34. Wooldridge L., et al. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280 (2005) 27491
35. Wooldridge L., et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur. J. Immunol. 37 (2007) 1323
36. Wyer J.R., et al. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. Immunity 10 (1999) 219
37. Zippelius A., et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res. 64 (2004) 2865